Germline-targeting epitope scaffold nanoparticles elicit rare broadly neutralizing antibody (bnAb) precursors against human immunodeficiency virus (HIV).
New strategy targets rare B cells for effective HIV vaccine development
- Post author:
- Post published:
- Post category:uncategorized